Home » Stocks » Elanco Animal Health

Elanco Animal Health Incorporated (ELAN)

Stock Price: $30.91 USD -0.63 (-2.00%)
Updated Oct 19, 2020 4:03 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 14.58B
Revenue (ttm) 2.80B
Net Income (ttm) -101.80M
Shares Out 471.85M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE 31.15
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $30.91
Previous Close $31.54
Change ($) -0.63
Change (%) -2.00%
Day's Open 31.62
Day's Range 30.56 - 31.63
Day's Volume 3,856,456
52-Week Range 15.17 - 34.09

More Stats

Market Cap 14.58B
Enterprise Value 15.24B
Earnings Date (est) Nov 6, 2020
Ex-Dividend Date n/a
Shares Outstanding 471.85M
Float 397.48M
EPS (basic) -0.25
EPS (diluted) -0.26
FCF / Share 0.35
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.99%
Payout Ratio n/a
Shares Short 26.26M
Short Ratio 6.57
Short % of Float 6.61%
Beta 1.04
PE Ratio n/a
Forward PE 31.15
P/FCF Ratio 101.42
PS Ratio 5.20
PB Ratio 2.26
Revenue 2.80B
Operating Income -130.90M
Net Income -101.80M
Free Cash Flow 143.80M
Net Cash -654.50M
Net Cash / Share -1.39
Gross Margin 57.12%
Operating Margin -4.67%
Profit Margin -3.60%
FCF Margin 5.13%
ROA 1.43%
ROE -1.71%
ROIC -1.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (15)

Buy 10
Overweight 0
Hold 5
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$30.17*
(-2.39% downside)
Low
23.0
Current: $30.91
High
37.0
Target: 30.17
*Average 12-month price target from 9 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue3,0713,0672,8892,9142,909
Revenue Growth0.14%6.15%-0.84%0.15%-
Gross Profit1,6011,4931,3951,5051,375
Operating Income157144-233-22.40-258
Net Income67.9086.50-311-47.90-211
Shares Outstanding369314293293-
Earnings Per Share0.180.28-1.06-0.16-
EPS Growth-35.71%----
Operating Cash Flow2244871741566.60
Capital Expenditures-197-127-79.50-103-79.80
Free Cash Flow27.0036094.3053.00-73.20
Cash & Equivalents345678323259-
Total Debt2,3552,472---
Net Cash / Debt-2,010-1,795323259-
Assets8,9868,9578,9408,100-
Liabilities3,4393,7591,1601,072-
Book Value5,5475,1987,7807,028-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Elanco Animal Health Incorporated
Country United States
Employees 6,000
CEO Jeffrey N. Simmons

Stock Information

Ticker Symbol ELAN
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NYSE: ELAN
IPO Date September 20, 2018

Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for companion and food animals. It offers companion animal disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production. The company sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. The company has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine; and strategic alliance with the Purdue University and Purdue Research Foundation. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.